Tower Research Capital (TRC)’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.4K | Buy |
|
|||||
|
2025
Q1 | $14.4K | Sell |
|
|||||
|
2024
Q4 | $16.9K | Sell |
|
|||||
|
2024
Q3 | $22.6K | Sell |
|
|||||
|
2024
Q2 | $56.5K | Buy |
|
|||||
|
2024
Q1 | $2.81K | Sell |
|
|||||
|
2023
Q4 | $25.4K | Sell |
|
|||||
|
2023
Q3 | $146K | Buy |
|
|||||
|
2023
Q2 | $7.29K | Sell |
|
|||||
|
2023
Q1 | $16K | Buy |
|
|||||
|
2022
Q4 | $15K | Sell |
|
|||||
|
2022
Q3 | $20K | Sell |
|
|||||
|
2022
Q2 | $21K | Buy |
|
|||||
|
2022
Q1 | $9K | Sell |
|
|||||
|
2021
Q4 | $21K | Buy |
|
|||||
|
2021
Q3 | $10K | Sell |
|
|||||
|
2021
Q2 | $50K | Sell |
|
|||||
|
2021
Q1 | $88K | Sell |
|
|||||
|
2020
Q4 | $103K | Sell |
|
|||||
|
2020
Q3 | $407K | Buy |
|
|||||
|
2020
Q2 | $74K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $20K | Sell |
|
|||||
|
2019
Q3 | $47K | Buy |
|
|||||
|
2019
Q2 | $4K | Sell |
|
|||||
|
2019
Q1 | $110K | Buy |
|
|||||
|
2018
Q4 | $15K | Sell |
|
|||||
|
2018
Q3 | $32K | Buy |
|
|||||
|
2018
Q2 | $7K | Sell |
|
|||||
|
2018
Q1 | $10K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $10K | Buy |
|
|||||
|
2017
Q2 | $5K | Buy |
|